These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36565202)

  • 1. Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy.
    Patlolla SH; Schaff HV; Nishimura RA; Eleid MF; Geske JB; Ommen SR
    J Am Heart Assoc; 2023 Jan; 12(1):e026661. PubMed ID: 36565202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
    Mentias A; Smedira NG; Krishnaswamy A; Reed GW; Ospina S; Thamilarasan M; Popovic ZB; Xu B; Kapadia SR; Desai MY
    J Am Coll Cardiol; 2023 Jan; 81(2):105-115. PubMed ID: 36631204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.
    Cavigli L; Fumagalli C; Maurizi N; Rossi A; Arretini A; Targetti M; Passantino S; Girolami F; Tomberli B; Baldini K; Tomberli A; Antoniucci D; Yacoub MH; Marchionni N; Stefano PL; Cecchi F; Olivotto I
    Int J Cardiol; 2018 Dec; 273():155-161. PubMed ID: 30213605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy.
    Cui H; Schaff HV; Geske JB; Lahr BD; Dearani JA; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1502-1509.e5. PubMed ID: 33223194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital Procedural Volume and Clinical Outcomes Following Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy.
    Altibi AM; Ghanem F; Zhao Y; Elman M; Cigarroa J; Nazer B; Song HK; Masri A
    J Am Heart Assoc; 2023 May; 12(10):e028693. PubMed ID: 37183831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011.
    Kim LK; Swaminathan RV; Looser P; Minutello RM; Wong SC; Bergman G; Naidu SS; Gade CL; Charitakis K; Singh HS; Feldman DN
    JAMA Cardiol; 2016 Jun; 1(3):324-32. PubMed ID: 27438114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive Cardiomyopathy.
    Yandrapalli S; Harikrishnan P; Andries G; Aronow WS; Panza JA; Naidu SS
    J Invasive Cardiol; 2022 Jan; 34(1):E8-E13. PubMed ID: 34919530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Septal Reduction Therapy on Acute Cardiovascular Events and All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy.
    Morita SX; Zhao Y; Hasegawa K; Fifer MA; Maurer MS; Reilly MP; Takayama H; Shimada YJ
    Int Heart J; 2021 Sep; 62(5):1035-1041. PubMed ID: 34544977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy.
    Butzner M; Maron MS; Sarocco P; Teng CC; Stanek E; Tan H; Robertson LA
    J Invasive Cardiol; 2022 Dec; 34(12):E866-E872. PubMed ID: 36288089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?
    Cui H; Schaff HV; Dearani JA; Lahr BD; Viehman JK; Geske JB; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):997-1006.e3. PubMed ID: 32977972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Surgical Ventricular Septal Reduction to Alcohol Septal Ablation Therapy in Patients with Hypertrophic Cardiomyopathy.
    Bourque C; Réant P; Bernard A; Leroux L; Bonnet G; Pernot M; Bisson A; Herbert J; Saint-Etienne C; Lafitte S; Fauchier L
    Am J Cardiol; 2022 Jun; 172():109-114. PubMed ID: 35351287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and Ethnic Disparities in the Trends and Outcomes of Cardiogenic Shock Complicating Peripartum Cardiomyopathy.
    Olanipekun T; Abe T; Effoe V; Egbuche O; Mather P; Echols M; Adedinsewo D
    JAMA Netw Open; 2022 Jul; 5(7):e2220937. PubMed ID: 35788668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score.
    Ralph-Edwards A; Woo A; McCrindle BW; Shapero JL; Schwartz L; Rakowski H; Wigle ED; Williams WG
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):351-8. PubMed ID: 15678046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience.
    Steggerda RC; Damman K; Balt JC; Liebregts M; ten Berg JM; van den Berg MP
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1227-34. PubMed ID: 25326737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy.
    Alashi A; Smedira NG; Popovic ZB; Fava A; Thamilarasan M; Kapadia SR; Wierup P; Lever HM; Desai MY
    J Am Heart Assoc; 2021 Feb; 10(3):e018527. PubMed ID: 33506683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality After Alcohol Septal Ablation vs. Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
    Yasuda R; Osawa I; Goto T; Hasegawa K; Fifer MA; Tower-Rader A; Reilly MP; Maurer MS; Zhao Y; Takayama H; Shimada YJ
    Circ Rep; 2024 Mar; 6(3):74-79. PubMed ID: 38464986
    [No Abstract]   [Full Text] [Related]  

  • 17. Periprocedural, Short-Term, and Long-Term Outcomes of Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A 20-Year Single-Center Experience.
    Karabulut U; Yılmaz Can Y; Duygu E; Karabulut D; Keskin K; Okay T
    Anatol J Cardiol; 2022 Apr; 26(4):316-324. PubMed ID: 35435843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
    Poon SS; Field M; Gupta D; Cameron D
    Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?
    Knyshov G; Lazoryshynets V; Rudenko K; Kravchuk B; Beshlyaga V; Zalevsky V; Rasputnyak O; Batsak B
    Interact Cardiovasc Thorac Surg; 2013 Jan; 16(1):5-9. PubMed ID: 23027595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
    Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.